Three worlds collide as a drug trafficker arranges a multi-cartel Fentanyl smuggling operation between Canada and the US, an architect recovering from addiction tracks down the truth behind her son’s narcotics involvement, and a university professor battles unexpected revelations about his research employer, a drug company with deep government influence bringing a new “non-addictive” painkiller to market.